These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20975529)

  • 21. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trial.
    Suh JW; Seung KB; Gwak CH; Kim KS; Hong SJ; Park TH; Kim SH; Choi YJ; Joo SJ; Tahk SJ; Kim HS
    Clin Ther; 2011 Aug; 33(8):1057-68. PubMed ID: 21816478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple testing of noninferiority hypotheses in active controlled trials.
    Hung HM; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.
    Dawson R; Lavori PW
    Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
    Prescrire Int; 2008 Oct; 17(97):206-12. PubMed ID: 19536941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-inferiority trials: the 'at least as good as' criterion.
    Laster LL; Johnson MF
    Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issues on the selection of non-inferiority margin in clinical trials.
    Hou Y; Wu XY; Li K
    Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.
    Vavken P
    Clin Orthop Relat Res; 2011 Sep; 469(9):2645-53. PubMed ID: 21246313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
    Tsong Y; Wang SJ; Hung HM; Cui L
    J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of intention to treat in analysis of noninferiority studies.
    Wiens BL; Zhao W
    Clin Trials; 2007; 4(3):286-91. PubMed ID: 17715258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The importance of equivalence trials in showing the usefulness of treatments].
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; de Haan M
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2162-6. PubMed ID: 14626832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and analysis of a 3-arm noninferiority trial with a prespecified margin for the hazard ratio.
    Hida E; Tango T
    Pharm Stat; 2018 Sep; 17(5):489-503. PubMed ID: 29984524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential tests for noninferiority and superiority.
    Brannath W; Bauer P; Maurer W; Posch M
    Biometrics; 2003 Mar; 59(1):106-14. PubMed ID: 12762447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous testing of noninferiority and superiority increases the false discovery rate.
    Ng TH
    J Biopharm Stat; 2007; 17(2):259-64. PubMed ID: 17365222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting clinical trial results of patient-perceived onset of effect in asthma: methods and results of a Delphi panel.
    Harding G; Leidy NK; Meddis D; Kleinman L; Wagner S; O'Brien CD
    Curr Med Res Opin; 2009 Jun; 25(6):1563-71. PubMed ID: 19445651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical issues and recommendations for noninferiority trials in oncology: a systematic review.
    Tanaka S; Kinjo Y; Kataoka Y; Yoshimura K; Teramukai S
    Clin Cancer Res; 2012 Apr; 18(7):1837-47. PubMed ID: 22317762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.